Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15572051rdf:typepubmed:Citationlld:pubmed
pubmed-article:15572051lifeskim:mentionsumls-concept:C0012984lld:lifeskim
pubmed-article:15572051lifeskim:mentionsumls-concept:C0376466lld:lifeskim
pubmed-article:15572051lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:15572051lifeskim:mentionsumls-concept:C0949653lld:lifeskim
pubmed-article:15572051lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:15572051lifeskim:mentionsumls-concept:C1882151lld:lifeskim
pubmed-article:15572051pubmed:issue6lld:pubmed
pubmed-article:15572051pubmed:dateCreated2004-12-1lld:pubmed
pubmed-article:15572051pubmed:abstractTextBrief periods of ischemia that precede sustained ischemia can markedly reduce infarct size (IS), a phenomenon that is known as ischemic preconditioning (IP). Several investigators have shown that elevation of the intracellular Ca(2+) level ([Ca(2+)](i)) during the antecedent brief periods of ischemia triggers the cardioprotective mechanism of IP. Since opening of Ca(2+) activated K(+) (K(Ca)) channels is reported to be cardioprotective, we hypothesized that these channels may be involved in the cardioprotective mechanism of IP. In anesthetized open-chest dogs, myocardial ischemia/reperfusion injury was created by occlusion of the left anterior descending coronary artery (LAD) for 90 min followed by 6 h of reperfusion. First, we showed that the treatment with NS1619, a K(Ca) channel opener, reduced IS (IS in NS1619 group and control group, 19.8 +/- 5.5% vs. 45.4 +/- 3.5% of the area at risk, P < 0.05). Next, four cycles coronary occlusion for 5 min and reperfusion (IP) were performed before the 90-min occlusion with or without the infusion of potent K(Ca) channel inhibitors, iberiotoxin (IbTX) and charybdotoxin (ChTX). IP markedly reduced IS (IS in the IP group was 8.2 +/- 1.8%, P < 0.01 vs. control group). Infusion of either of K(Ca) channel blockers during IP blunted the IS-limiting effect of IP (IS in the IP + IbTX and IP + ChTX groups was 30.7 +/- 7.0% and 35.5 +/- 3.7%, respectively, P < 0.05, vs. IP group). However, the cardioprotective effect of IP was not blunted by the treatment with ChTX when treated only during reperfusion (14.0 +/- 4.1%). Thus, we conclude that the opening of K(Ca) channel is involved in early trigger phase of the molecular mechanism of IP.lld:pubmed
pubmed-article:15572051pubmed:languageenglld:pubmed
pubmed-article:15572051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15572051pubmed:citationSubsetIMlld:pubmed
pubmed-article:15572051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15572051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15572051pubmed:statusMEDLINElld:pubmed
pubmed-article:15572051pubmed:monthDeclld:pubmed
pubmed-article:15572051pubmed:issn0022-2828lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:TomoikeHitono...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:HoriMasatsugu...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:KitakazeMasaf...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:TakashimaSeij...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:LiaoYulinYlld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:NodeKoichiKlld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:AsanumaHirosh...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:SanadaShojiSlld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:AsanoYoshihir...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:KimJiyoongJlld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:FujitaMasashi...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:ShinozakiYosh...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:HirataAkioAlld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:ShintaniYasun...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:FukushimaTomi...lld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:OkudaHirokoHlld:pubmed
pubmed-article:15572051pubmed:authorpubmed-author:NagamachiYoko...lld:pubmed
pubmed-article:15572051pubmed:issnTypePrintlld:pubmed
pubmed-article:15572051pubmed:volume37lld:pubmed
pubmed-article:15572051pubmed:ownerNLMlld:pubmed
pubmed-article:15572051pubmed:authorsCompleteYlld:pubmed
pubmed-article:15572051pubmed:pagination1213-8lld:pubmed
pubmed-article:15572051pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:meshHeadingpubmed-meshheading:15572051...lld:pubmed
pubmed-article:15572051pubmed:year2004lld:pubmed
pubmed-article:15572051pubmed:articleTitleOpening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts.lld:pubmed
pubmed-article:15572051pubmed:affiliationDepartment of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Japan.lld:pubmed
pubmed-article:15572051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15572051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15572051lld:pubmed